Breast cancer (early & locally advanced)
Breast cancer (early & locally advanced): diagnosis and treatment
Summary
The advice in this guideline covers: some of the tests and treatments that patients with early and locally advanced breast cancer should be offered, in particular:– reducing the amount of surgery under your arm– breast reconstruction when breast conservation is not possible– ...
NICE has produced separate advice for the care of patients with advanced breast cancer and people who have a family history of the disease.
This guideline updates the following technology appraisals:
- TA107 Breast cancer (early) - trastuzumab (published August 2006)
- TA108 Breast cancer (early) - paclitaxel (published September 2006)
- TA109 Breast cancer (early) - docetaxel (published September 2006).
NICE and the Department of Health are currently reviewing the future position on updating technology appraisals within clinical guidelines, with particular reference to implications for the funding direction on technology appraisals. In the meantime, the technology appraisal guidance remains available and should continue to be followed. The statutory funding direction remains in place for the recommendations contained in the technology appraisal guidance.
Guidance documents
Implementing this guidance
Other information
Expected review date: February 2012
About this guidance
Clinical guidelines CG80
Issued: February 2009
How this guidance was produced